Core Viewpoint - Hanbang Technology's stock performance shows a slight increase, with notable financing activities and a mixed financial performance in recent months [1][2]. Group 1: Stock Performance and Financing - On October 28, Hanbang Technology's stock rose by 0.33%, with a trading volume of 27.33 million yuan [1]. - The financing data indicates that on the same day, Hanbang Technology had a financing buy amount of 4.26 million yuan and a net financing buy of 0.48 million yuan, with a total financing balance of 80.05 million yuan, accounting for 10.66% of its market capitalization [1]. - There were no short selling activities reported on October 28, with a short selling balance of 0 yuan [1]. Group 2: Financial Performance - For the period from January to September 2025, Hanbang Technology achieved a revenue of 506 million yuan, representing a year-on-year growth of 4.61% [2]. - The net profit attributable to the parent company for the same period was 37.02 million yuan, showing a year-on-year decrease of 17.27% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Hanbang Technology was 8,687, a decrease of 7.31% from the previous period [2]. - The average number of circulating shares per shareholder increased by 7.89% to 1,904 shares [2]. - Since its A-share listing, Hanbang Technology has distributed a total of 8.80 million yuan in dividends [3].

Group 1 - The company, Hanbang Technology (688755.SH), reported a total operating revenue of 506 million yuan for the first three quarters of 2025, representing a year-on-year increase of 4.61% [1] - The net profit attributable to shareholders of the parent company was 37.0172 million yuan, showing a year-on-year decline of 17.27% [1] - The basic earnings per share were reported at 0.49 yuan [1]

经与会董事审议，并对议案进行了投票表决，通过了以下决议： 证券代码：688755 证券简称：汉邦科技 公告编号：2025-036 江苏汉邦科技股份有限公司 第二届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 江苏汉邦科技股份有限公司（以下简称"公司"）第二届董事会第二次会议 于 2025 年 10 月 27 日以现场及通讯表决相结合的方式召开，会议通知于 2025 年 10 月 24 日以电子邮件形式向全体董事和高级管理人员发出。本次会议由董事 长张大兵先生主持，会议应出席董事 9 人，实际出席董事 9 人。本次会议的召集、 召开和表决程序符合《中华人民共和国公司法》等法律、法规和《公司章程》的 有关规定。 二、董事会会议审议情况 江苏汉邦科技股份有限公司 董事会 2025 年 10 月 29 日 （一）审议通过了《关于<公司 2025 年第三季度报告>的议案》 表决结果：9 票同意，0 票反对，0 票弃权。 本议案提交董事会审议前，已经董事会审计委员会审议通过。 经审议 ...

Group 1 - The company Hanbang Technology (SH 688755) announced on October 28 that it has recognized credit impairment losses and asset impairment losses totaling 12.56 million yuan for the third quarter of 2025, impacting the total profit of the consolidated financial statements by the same amount [1] - The impairment provision is based on the principle of prudence and objectively reflects the actual situation of the company's assets, indicating no harm to the interests of the company and its shareholders, and will not have a significant impact on the company's production and operations [1] - For the first half of 2025, the revenue composition of Hanbang Technology is as follows: small molecule drug separation and purification equipment accounted for 70.99%, large molecule drug separation and purification equipment accounted for 22.94%, and others accounted for 6.07% [1] Group 2 - As of the report date, Hanbang Technology has a market capitalization of 4 billion yuan [1]

Company Performance - Hanbang Technology reported a revenue of approximately 506 million yuan for the first three quarters of 2025, representing a year-on-year increase of 4.61% [1] - The net profit attributable to shareholders was approximately 37.02 million yuan, showing a year-on-year decrease of 17.27% [1] - Basic earnings per share were 0.49 yuan, down 27.94% year-on-year [1] Market Context - As of the report, Hanbang Technology's market capitalization stood at 4 billion yuan [2] - The A-share market has recently surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology stocks leading the way [2]

Financial Performance - The company's operating revenue for the third quarter was ¥157,007,316.07, representing a year-on-year increase of 1.67%[3] - The total profit for the quarter was ¥10,780,382.79, showing a significant increase of 28.45% compared to the same period last year[3] - The net profit attributable to shareholders was ¥9,219,615.06, which is an increase of 30.64% year-on-year[3] - The net profit excluding non-recurring gains and losses decreased by 14.28% to ¥5,920,319.86 for the quarter[3] - Total operating revenue for the first three quarters of 2025 reached ¥505,750,487.24, an increase of 4.7% compared to ¥483,460,857.56 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was ¥37,017,189.52, a decrease of 17.3% from ¥44,742,386.81 in the same period of 2024[21] - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.49, down from ¥0.68 in the same period of 2024[21] Assets and Liabilities - The total assets at the end of the reporting period reached ¥1,852,075,258.01, marking a 39.80% increase from the end of the previous year[4] - Total current assets increased to ¥1,539,171,762.97 as of September 30, 2025, up from ¥1,064,361,597.76 at the end of 2024, reflecting a growth of approximately 44.5%[14] - Total assets reached ¥1,852,075,258.01, up from ¥1,324,825,113.36, indicating a growth of approximately 40%[15] - Total current liabilities increased to ¥584,769,517.50 from ¥540,170,081.02, reflecting a rise of about 8.2%[15] - Total liabilities as of the reporting date were ¥636,601,718.44, up from ¥585,192,054.28 in the previous year[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,687[11] - The largest shareholder, Zhang Dabin, holds 20,903,485 shares, representing 23.75% of total shares[11] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥57,531,897.16, reflecting a decrease of 39.19%[3] - Cash flow from operating activities for the first three quarters of 2025 was ¥57,531,897.16, a decrease of 39.1% compared to ¥94,603,601.62 in the first three quarters of 2024[23] - Cash inflow from investment activities in the first three quarters of 2025 totaled ¥8,024,117.74, compared to ¥2,823.01 in the same period of 2024[23] - Cash outflow from investment activities for the first three quarters of 2025 was ¥155,871,408.81, significantly higher than ¥25,617,655.46 in the same period of 2024[23] - Cash inflow from financing activities in the first three quarters of 2025 was ¥464,913,600.00, with no corresponding figure for the same period of 2024[23] - The net cash flow from financing activities was $411,973,083.57, compared to a negative cash flow of $7,850,711.53 in the previous period[25] - The total cash and cash equivalents at the end of the period amounted to $773,302,144.15, an increase from $530,868,273.80 in the previous period[25] - The cash inflow from financing activities totaled $473,973,741.56, while cash outflow from financing activities was $62,000,657.99[25] - The company experienced a negative impact of $2,445,377.61 from foreign exchange fluctuations on cash and cash equivalents[25] - The net increase in cash and cash equivalents for the period was $319,212,312.05, compared to $58,374,808.66 in the previous period[25] - The company repaid $24,000,000.00 in debt during the period, up from $16,990,000.00 in the previous period[25] - Dividend payments and interest paid amounted to $8,751,757.99, compared to $2,783,411.53 in the previous period[25] - The company received $9,050,000.00 in cash from borrowings, compared to $15,000,000.00 in the previous period[25] - The cash received from other financing activities was $10,141.56, with no previous period data available[25] Research and Development - Research and development expenses totaled ¥10,093,247.45, accounting for 6.43% of operating revenue, an increase of 0.54 percentage points[4] Other Information - The company has no significant changes in the participation of major shareholders in margin trading and securities lending activities[12] - Deferred revenue increased to ¥38,511,611.03 in 2025 from ¥31,929,120.69 in 2024[16] - The company does not plan to apply new accounting standards starting from 2025[26]

证券代码：688755 证券简称：汉邦科技 公告编号：2025-037 江苏汉邦科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 11 月 18 日（星期二）至 11 月 24 日（星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR@hanbon.com.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 江苏汉邦科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 29 日发 布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 2025 年 11 月 25 日（星期二） 14:00-15:00 举行 2025 ...

证券代码：688755 证券简称：汉邦科技 公告编号：2025-038 一、计提资产减值准备情况概述 江苏汉邦科技股份有限公司（以下简称"汉邦科技"或"公司"）根据《企 业会计准则》等相关规定，结合公司的实际情况，为客观公允地反映公司截至 2025 年 9 月 30 日的财务状况及经营成果，基于谨慎性原则，对合并报表范围内 的有关资产计提信用及资产减值准备。 江苏汉邦科技股份有限公司 关于 2025 年第三季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 公司以预期信用损失为基础，对合同资产进行了减值测试。对存货资产，在 资产负债表日，存货成本高于其可变现净值及陈旧和滞销的存货，计提存货跌价 准备。经测试，本次需计提的资产减值损失准备金额共计 1,000.36 万元。 三、计提资产减值准备对公司的影响 2025 年第三季度，公司计提信用减值损失及资产减值损失共计 1,255.56 万 元，对公司合并报表利润总额影响 1,255.56 万元（合并利润总额未计算所得税 影响）。本次计提减值准备事项是基 ...

Group 1 - The core point of the article highlights the fundraising activities of companies listed on the STAR Market, with a total of 10 companies raising 16.736 billion yuan this year, averaging 1.674 billion yuan per company [1][2] - Xi'an Yicai leads in fundraising with 4.636 billion yuan, primarily for the second phase of its silicon industry base project [1] - He Yuan Bio follows with 2.599 billion yuan raised for the construction of a plant-based recombinant human serum albumin production base and other projects [1] Group 2 - The average initial offering price of STAR Market stocks this year is 20.76 yuan, with the highest being 47.27 yuan for Ying Shi Innovation [1][2] - The issuance price of Xi'an Yicai and Yitang shares is relatively low at 8.62 yuan and 8.45 yuan respectively [1] - The issued price-earnings ratios range from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] Group 3 - The majority of the newly issued STAR Market companies are concentrated in Jiangsu, Hubei, and Guangdong provinces, each with two companies [2] - The top fundraising regions are Shaanxi, Hubei, and Guangdong, with amounts of 4.636 billion yuan, 3.767 billion yuan, and 3.538 billion yuan respectively [2] - Two companies have issuance price-earnings ratios above the industry average, while five companies are below it [2]

Core Insights - The total amount raised by companies on the STAR Market this year has reached 15.136 billion yuan, with an average fundraising of 1.682 billion yuan per company [1][2] - The highest fundraising company is Xian Yicai, which raised 4.636 billion yuan, primarily for its silicon industry base project [1] - The average initial offering price for STAR Market stocks this year is 21.09 yuan, with the highest being 47.27 yuan for Ying Shi Innovation [1][2] Fundraising Overview - A total of 9 companies have issued new shares on the STAR Market this year, with 5 companies raising over 1 billion yuan and 3 companies raising between 500 million to 1 billion yuan [1] - The companies with significant fundraising include: - Xian Yicai: 4.636 billion yuan - He Yuan Biological: 2.599 billion yuan - Yi Tang Co.: 2.497 billion yuan - Ying Shi Innovation: 1.938 billion yuan - Xing Fu Electronics: 1.168 billion yuan [1] Pricing and Valuation - The average issuance price for STAR Market stocks is 21.09 yuan, with the highest price at 47.27 yuan for Ying Shi Innovation and the lowest at 8.45 yuan for Yi Tang Co. [1] - The issuance price-to-earnings (P/E) ratio ranges from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] - Yi Tang Co. has the highest P/E ratio at 51.55, while several companies have P/E ratios below the industry average [2] Regional Distribution - The majority of the companies issued this year are concentrated in Beijing, Jiangsu, and Hubei, with each region having 2 companies [2] - The top fundraising regions are Shaanxi, Hubei, and Beijing, with amounts of 4.636 billion yuan, 3.767 billion yuan, and 3.359 billion yuan respectively [2]